Bristol-Myers Squibb Co at Barclays Global Healthcare Conference (Virtual) Transcript
Okay. Good afternoon. My name is Carter Gould. I am a senior analyst here at Barclays. Good afternoon, and welcome to our fireside chat with Bristol-Myers Squibb. Representing the company is CFO, David Elkins, who is joining us by phone.
David, thank you very much for joining us today, and looking forward to the conversation.
As am I, Carter. Thanks for having me.
Questions & Answers
Great. David, so we're just going to jump right in. I guess the question we get asked the most often is just around Bristol's ability to really sort of manage margins over the midterm with, yes, a number of launches, but also, some LOEs starting to hit. So I guess, if you could just kind of help us think through that period, what gives you confidence in some of the push/pulls, say, between now and,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |